163 related articles for article (PubMed ID: 32175789)
21. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
22. Staging of nasopharyngeal carcinoma: evaluation of N-staging by Ho and UICC/AJCC systems. Union Internationale Contre le Cancer. American Joint Committee for Cancer.
Lee AW; Foo W; Poon YF; Law CK; Chan DK; O SK; Tung SY; Ho JH
Clin Oncol (R Coll Radiol); 1996; 8(3):146-54. PubMed ID: 8814368
[TBL] [Abstract][Full Text] [Related]
23. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Wen T; Wang Z; Li Y; Li Z; Che X; Fan Y; Wang S; Qu J; Yang X; Hou K; Zhou W; Xu L; Li C; Wang J; Liu J; Chen L; Zhang J; Qu X; Liu Y
Cancer Immunol Res; 2017 Jul; 5(7):524-534. PubMed ID: 28619967
[TBL] [Abstract][Full Text] [Related]
24. Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
Donnem T; Hald SM; Paulsen EE; Richardsen E; Al-Saad S; Kilvaer TK; Brustugun OT; Helland A; Lund-Iversen M; Poehl M; Olsen KE; Ditzel HJ; Hansen O; Al-Shibli K; Kiselev Y; Sandanger TM; Andersen S; Pezzella F; Bremnes RM; Busund LT
Clin Cancer Res; 2015 Jun; 21(11):2635-43. PubMed ID: 25680376
[TBL] [Abstract][Full Text] [Related]
25. The immune score as a new possible approach for the classification of cancer.
Galon J; Pagès F; Marincola FM; Thurin M; Trinchieri G; Fox BA; Gajewski TF; Ascierto PA
J Transl Med; 2012 Jan; 10():1. PubMed ID: 22214470
[TBL] [Abstract][Full Text] [Related]
26. World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016.
Galon J; Lugli A; Bifulco C; Pages F; Masucci G; Marincola FM; Ascierto PA
J Transl Med; 2017 Oct; 15(1):212. PubMed ID: 29058595
[TBL] [Abstract][Full Text] [Related]
27. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?
Yoon HM; Ryu KW; Nam BH; Cho SJ; Park SR; Lee JY; Lee JH; Kook MC; Choi IJ; Kim YW
J Am Coll Surg; 2012 Jan; 214(1):88-96. PubMed ID: 22036661
[TBL] [Abstract][Full Text] [Related]
28. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
29. CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Paulsen EE; Kilvaer T; Khanehkenari MR; Maurseth RJ; Al-Saad S; Hald SM; Al-Shibli K; Andersen S; Richardsen E; Busund LT; Bremnes R; Donnem T
Neoplasia; 2015 Nov; 17(11):839-48. PubMed ID: 26678911
[TBL] [Abstract][Full Text] [Related]
30. Immunoscore in mismatch repair-proficient and -deficient colon cancer.
Wirta EV; Seppälä T; Friman M; Väyrynen J; Ahtiainen M; Kautiainen H; Kuopio T; Kellokumpu I; Mecklin JP; Böhm J
J Pathol Clin Res; 2017 Jul; 3(3):203-213. PubMed ID: 28770104
[TBL] [Abstract][Full Text] [Related]
31. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
[TBL] [Abstract][Full Text] [Related]
32. Immunoscore assay for the immune classification of solid tumors: Technical aspects, improvements and clinical perspectives.
Marliot F; Lafontaine L; Galon J
Methods Enzymol; 2020; 636():109-128. PubMed ID: 32178816
[TBL] [Abstract][Full Text] [Related]
33. [Immunology and personalized medicine in oncology].
Zinzindohoué F; Zeitoun G; Berger A; Todosi AM; Marliot F; Lagorce C; Galon J; Pagès F
Bull Cancer; 2014 Jun; 101 Suppl 1():S12-7. PubMed ID: 24966077
[TBL] [Abstract][Full Text] [Related]
34. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.
Donnem T; Kilvaer TK; Andersen S; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Brustugun OT; Helland A; Lund-Iversen M; Solberg S; Gronberg BH; Wahl SG; Helgeland L; Fløtten O; Pohl M; Al-Shibli K; Sandanger TM; Pezzella F; Busund LT; Bremnes RM
Ann Oncol; 2016 Feb; 27(2):225-32. PubMed ID: 26578726
[TBL] [Abstract][Full Text] [Related]
35. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W
PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
37. Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
Mukherjee G; Bag S; Chakraborty P; Dey D; Roy S; Jain P; Roy P; Soong R; Majumder PP; Dutt S
PLoS One; 2020; 15(11):e0242058. PubMed ID: 33211709
[TBL] [Abstract][Full Text] [Related]
38. Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
Mlecnik B; Torigoe T; Bindea G; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Hirohashi Y; Furuhata T; Takemasa I; Patel P; Vora H; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Yoshino T; Taniguchi H; Bifulco C; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson E; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Marliot F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; Van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Marincola FM; Ascierto PA; Fox BA; Pagès F; Kawakami Y; Galon J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139506
[TBL] [Abstract][Full Text] [Related]
39. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
40. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
